Diagnostic Products Corporation (DPC) has announced that MBL of Japan has granted DPC a license to develop and commercialize diagnostic antinuclear antibody (ANA) assays on its IMMULITE immunochemistry analyzers, and applications for the DPC ANA lineBlot assay. “The combination of IMMULITE automation and the ANA technology represents a significant step forward in autoimmune testing,” said Read more about Diagnostic Products Announces License Agreement With MBL[…]